The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide, the active ingredient in Ozempic and Wegovy, two prescription medications used for weight loss.

A notice on the FBI's website warns that the fraudulent drugs purporting to contain semaglutide have been found instead to contain "compounded mixtures of unknown drugs that do not contain semaglutide, drugs with high levels of impurities, and unsafe or unapproved drugs."

The health risks of taking the "misrepresented drugs" include everything from cardiac and gastrointestinal disorders to nervous system disorders, psychiatric disorders and death, according to the FBI.

Read more at Good Morning America >>

See the FBI-issued Public Service Announcement >>